Creating VIP Corps to Reduce Maternal Deaths
ConditionMaternal Morbidity and Mortality
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-30
SponsorAnn Coker
About this trial
The goal of this observational study is to create and rigorously evaluate a violence intervention and prevention corps (VIP Corps) training using a randomized controlled trial among undergraduate and professional students; and to develop a novel maternal injury surveillance system (MISS) to complement an existing maternal violent death registry in Kentucky.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Students enrolled in a helping professions program
18 years of age through 30 years of age
Students whom will have direct interaction with patients or clients that may experience interpersonal violence (IPV)
Disqualifiers
Students not enrolled in a helping professions program
Students under age 18 or over age 30
Students with no direct interaction with patients or clients
Trial design
Design model
Parallel
Treatments tested in this trial
The Big 3
BehavioralOur research team has developed an online, interactive learning management system (LMS) training. This training seeks to provide helping professionals with information and resources to identify, intervene, and prevent maternal injuries from interpersonal violence, substance use/disorder (IPV and SU/D). This training will provide healthcare professionals with the knowledge, skills, and efficacy to intervene and build capacity for prevention of maternal injuries and death due to violence.
Implementation and Effectiveness of VIP Corps Training
BehavioralImplement and evaluate the effectiveness of VIP Corps training aimed at students enrolled in helping professions in their last program year. intervention efficacy to change in students' knowledge, attitudes, and practices of intimate partner violence (IPV) screening, detection, and referrals; participant practices will be the primary, longer-term outcome; while changes in knowledge and attitudes will be short-term outcomes. Secondary outcomes will include changes in detecting symptoms of a) SU/D and b) depression and/or anxiety and providing appropriate resources.
Treatment groups
2,800 Participants
are divided into 2 treatment groupsGroup A: Maternal Injury and Death InterventionExperimental treatment 1 intervention
Group B: Development of a Maternal Injury Surveillance SystemActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Knowledge and attitudes toward intimate partner violence (IPV) among pregnant and postpartum people.
Change in knowledge of intimate partner violence (IPV) and attitudes toward those experiencing IPV by condition over time. Knowledge of pregnancy-associated causes of maternal mortality and morbidity created for this randomized controlled trial (RCT). This is a 17-item scale ranging from 0-35 with higher scores indicating greater (accurate) knowledge.
Time frame
Year 2 - Year 42
Knowledge and attitudes toward substance use among pregnant and postpartum people.
Change in knowledge of substance use and attitudes toward those using substances or having a substance use disorder by condition over time. Attitudes toward pregnant or postpartum people experiencing: a) intimate partner violence (IPV), substance use, and anxiety or depression. This measure is based on the Domestic Violence Myth Acceptance and expanded to substance use and anxiety or depression. 45 items and 3 subscales. Response options: 1-5 indicating ranging from strongly agree to strongly disagree. Lower scores are desired indicating greater acceptance and increased willingness to address intimate partner violence (IPV), substance use, and anxiety or depression among pregnant or postpartum people.
Time frame
Year 2 - Year 43
Knowledge and attitudes toward anxiety or depression among pregnant or postpartum people.
Change in knowledge of anxiety or depression and attitudes toward those with anxiety or depression by condition over time. The Violence Against Women Health Care Provider Survey expanded to providers' willingness to ask clients about: a) Intimate partner violence (IPV), b) substance use, and c) anxiety or depression. 41 items querying self-confidence and actions in asking clients about risk factors for maternal morbidity. The response options 1-5 indicate strongly agree to strongly disagree. Higher scores are desired as indicators of greater self confidence and likelihood of actions with clients.
Time frame
Year 2 - Year 4Secondary outcomes
1
Participants' (care provider) self-report of asking pregnant or postpartum people about intimate partner violence (IPV), substance use, and anxiety or depression.
Change in willingness, perceived efficacy, reports of asking clients about intimate partner violence (IPV) by condition and over time. New Bystander Action Survey developed for this randomized controlled trial (RCT). There are 20 items that measure the opportunity to take action with clients, friends or family members; actions taken, and perceived impact. There are 6 response options ranging from 0 times to more than 12 times (in the past 6 months). More actions and a higher score, are desired as indicators of greater actions to identify risk of maternal morbidity and provide resources to reduce this risk.
Time frame
Year 3 - Year 5Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ann Coker
Lead sponsor
University of Kentucky
Sponsor institution
Department of Health and Human Services
Collaborator
Source ClinicalTrials.gov